Terez, Margie V.

HRN: 09-06-12  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/17/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
05/17/2022
05/23/2022
IV
500 Mg
Q8
Abdominal Pain
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: